RA Capital Management Pivots to Metaverse Medicines
BOSTON, April 1, 2022 /PRNewswire/ -- RA Capital Management, LP ("RA Capital"), a leading investor in real-world healthcare, today announced the launch of its Meta Strategy, which will focus on developing new medicines, diagnostics, vaccines, and life science platforms in the metaverse.
- BOSTON, April 1, 2022 /PRNewswire/ -- RA Capital Management, LP ("RA Capital"), a leading investor in real-world healthcare, today announced the launch of its Meta Strategy, which will focus on developing new medicines, diagnostics, vaccines, and life science platforms in the metaverse.
- By pivoting to metaverse investments, RA Capital will continue to support companies with value-add capital, particularly during volatile periods in the real world.
- Due to the efficiency of R&D in the metaverse, RA Capital expects within hours to have cured all meta diseases.
- RA Capital does not yet have plans to initiate any investments in the metaverse.